$AKRX Company News Speculators live by the sword, die

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$AKRX Company News

Speculators live by the sword, die by the sword 3:13 p.m. July 8, 2014 - The Trading Deck
Dow, Nasdaq nail the breakout point 10:36 a.m. June 27, 2014 - Michael Ashbaugh
From tiny Akorns grow mighty oaks? 11:03 a.m. Nov. 21, 2013 - The Trading Deck
Rail-Splitter's top small-cap bets are worth watching 12:34 p.m. Nov. 4, 2013 - Insider Monkey
Akorn to buy Hi-Tech for $640 million in cash 8:02 a.m. Aug. 27, 2013 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:20 p.m. July 23, 2012 - MarketWatch
Corrective bounce, or sustainable upturn? 10:59 a.m. June 6, 2012 - Michael Ashbaugh
Charting a bearish double top 12:11 p.m. May 15, 2012 - Michael Ashbaugh
Charting a bearish double top 11:45 a.m. May 15, 2012 - Michael Ashbaugh
Wednesday’s biggest gaining and declining stocks 6:02 p.m. March 7, 2012 - Sue Chang
Tuesday’s biggest gaining and declining stocks 5:23 p.m. March 6, 2012 - MarketWatch
Stocks to watch Tuesday: Nutrisystem, Jakks 8:00 a.m. March 6, 2012 - MarketWatch
S&P 500 scratches out three-year high 12:07 p.m. March 2, 2012 - Michael Ashbaugh
Stocks to watch Friday: LinkedIn, LeapFrog, Nuance 7:46 a.m. Feb. 10, 2012 - MarketWatch
S&P 500 vies for positive 2011 finish 12:09 p.m. Dec. 23, 2011 - Michael Ashbaugh
S&P, Nasdaq retest major support 12:51 p.m. Dec. 12, 2011 - Michael Ashbaugh
U.S. markets survive test of major support 10:57 a.m. Nov. 2, 2011 - Michael Ashbaugh
Akorn rallies on earnings, M&A deal 1:59 p.m. Aug. 2, 2011 - Val Brickates Kennedy
Drug stocks slip; Emergent rallies 1:28 p.m. May 26, 2011 - Val Brickates Kennedy
Drug stocks gain; Derma, Elan climb 3:51 p.m. May 25, 2011 - Val Brickates Kennedy


AbbVie's Humira Positive in Phase III Skin Disease Study - Analyst Blog 5:05 p.m. Sept. 12, 2014 - Zacks.com
5 Top Stocks With Rising Earnings Estimates 7:02 a.m. Sept. 12, 2014 - Investors Business Daily
Wall Street Breakfast: EU Places New Sanctions On Russia, U.S. To Follow 6:32 a.m. Sept. 12, 2014 - Seeking Alpha
Akorn In Second Test Of 10-Week Line 5:09 p.m. Sept. 11, 2014 - Investors Business Daily
Akorn reportedly eyeing tax inversion deal 4:07 p.m. Sept. 11, 2014 - Seeking Alpha
Actavis' Bystolic Combination Gets Negative FDA Panel Vote - Analyst Blog 4:45 p.m. Sept. 10, 2014 - Zacks.com
10 Stocks with 5-Year Returns of 1,500%-Plus 5:10 a.m. Sept. 10, 2014 - InvestorPlace.com
Actavis' Antibiotic under FDA Review, Response in 1Q15 - Analyst Blog 5:20 p.m. Sept. 8, 2014 - Zacks.com
Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint - Analyst Blog 5:05 p.m. Sept. 5, 2014 - Zacks.com
Salix, Gilead Among 5 Top Medical Leaders To Watch 4:06 p.m. Sept. 5, 2014 - Investors Business Daily
Actavis' Gastrointestinal Drug Under FDA Priority Review - Analyst Blog 4:30 p.m. Sept. 4, 2014 - Zacks.com
Will This Price Target Increase Help Akorn (AKRX) Stock Today? 9:27 a.m. Sept. 4, 2014 - TheStreet.com
Akorn (AKRX): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape 8:54 a.m. Sept. 3, 2014 - Zacks.com
UCB Files Patent Infringement Lawsuit vs. Actavis - Analyst Blog 4:40 p.m. Aug. 28, 2014 - Zacks.com
Market-Caps and Stock Selection for Maximum Gains - Screen of the Week 4:11 a.m. Aug. 26, 2014 - Zacks.com
Actavis Up on Positive Phase III Ceftazidime-Avibactam Data - Analyst Blog 4:30 p.m. Aug. 21, 2014 - Zacks.com
Should You Get Rid of Corium International (CORI) Now? - Tale of the Tape 8:55 a.m. Aug. 20, 2014 - Zacks.com
Akorn (AKRX) Hits New Lifetime High Today 9:45 a.m. Aug. 19, 2014 - TheStreet.com
Mallinckrodt Acquires Questcor, to Join S&P 500 As Well - Analyst Blog 4:30 p.m. Aug. 18, 2014 - Zacks.com
Supernus's SPN-810 Gets Fast Track Status for ADHD - Analyst Blog 1:30 p.m. Aug. 18, 2014 - Zacks.com


Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 9:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Restaurant Openings, Financial Releases, Completed Projects, Regulatory Updates, and Strategic Acquisitions - Research Reports on El Pollo Loco, SunEdison, Workday, PCG and Akorn 8:30 a.m. Sept. 5, 2014 - PR Newswire - PRF
Akorn Completes Acquisition of VersaPharm 8:51 a.m. Aug. 12, 2014 - GlobeNewswire
Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed 9:20 a.m. Aug. 7, 2014 - PR Newswire - PRF
Akorn Reports Preliminary 2014 Second Quarter Results 6:05 a.m. Aug. 5, 2014 - GlobeNewswire
Global Parkinson%s Disease Market 2014-2018 6:42 p.m. July 28, 2014 - PR Newswire - PRF
Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information 11:34 a.m. July 15, 2014 - GlobeNewswire
Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt 6:50 a.m. July 2, 2014 - PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 6:40 a.m. June 27, 2014 - PR Newswire - PRF
Akorn Divests ECR Pharmaceuticals to Valeant 11:11 a.m. June 20, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Names Craig R. Skenes as Vice President, Business Development 4:05 p.m. June 16, 2014 - BusinessWire - BZX
Pharma Stocks Review -- Research on Akorn, Questcor Pharma, Nektar Therapeutics, and Endocyte 8:00 a.m. June 5, 2014 - PR Newswire - PRF
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co. 7:20 a.m. May 16, 2014 - PR Newswire - PRF
Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn 11:30 a.m. May 9, 2014 - PR Newswire - PRF
Akorn to Acquire VersaPharm for $440 Million 9:19 a.m. May 9, 2014 - BusinessWire - BZX
Akorn Reports 2014 First Quarter Results 7:03 a.m. May 6, 2014 - BusinessWire - BZX
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Actavis to Acquire Four Products from Akorn 4:15 p.m. April 17, 2014 - PR Newswire - PRF
Akorn Completes Acquisition of Hi-Tech Pharmacal 9:21 a.m. April 17, 2014 - BusinessWire - BZX
Repligen Corporation Set to Join the S&P SmallCap 600 5:53 p.m. April 15, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 205

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 196

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 286

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 207

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 204

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 405

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 193

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 253

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 330

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 238

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Elis Capital Structure Overview and Voting Rights Update

Updated Category News Views 292

Elis Capital Structure Overview Elis, a prominent player in the services sector, is committed to providing transparency regarding its capital structure. As of the recent assessment, the company detailed the number of shares that constitute its capital along with the total number of voting rights. Share Capital and Voting Rights According to French legal requirements,...

Continue Reading
A. Walker & Company Secures $50 Million for Housing Projects

Updated Category News Views 244

A. Walker & Company Secures Major Capital Commitments A. Walker & Co. recently secured a significant capital commitment totaling up to $75 million, including an initial $50 million specifically set aside for affordable housing development. This funding is a critical step towards increasing the availability of multifamily housing that can effectively serve the needs of...

Continue Reading
ClorDiSys Enhances Sterilization Capabilities with Expansion

Updated Category News Views 228

ClorDiSys Expands Sterilization Operations ClorDiSys Solutions, LLC has announced a significant expansion in its sterilization facilities, designed to address the growing demand for its chlorine dioxide-based sterilization services. This expansion includes the addition of new chambers, which will effectively double the company’s processing capacity. With the new...

Continue Reading
Star Equity's KBS Builders Secures Major Contracts Worth $5.2M

Updated Category News Views 173

KBS Builders Secures Significant Commercial Contracts Star Equity Holdings, Inc. is excited to announce that its subsidiary, KBS Builders, has successfully signed two major contracts worth a total of $5.2 million. These contracts focus on the manufacturing of housing units, promising to contribute positively not only to KBS's growth but also to addressing the ongoing...

Continue Reading
Navigating the Startup Jungle: Break Free from Traps

Updated Category News Views 158

Understanding the Existing Market Trap A fresh approach from the creators of Play Bigger reveals the hidden costs startups face. The new book titled The Existing Market Trap: A Primer presents a timely exploration into why many startups struggle to gain traction. Co-authors Al Ramadan, Christopher Lochhead, alongside new contributors Jason Wellcome and Mary Gr

Continue Reading